Primer on Urology

Christopher R. Chapple is an Emeritus Consultant Urological Surgeon at Sheffield Teaching Hospitals, Honorary Professor at the University of Sheffield, and Visiting Professor at Sheffield Hallam University. He is particularly interested in the functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms and provided an NHS tertiary service in lower urinary tract reconstructive surgery. He trained at the Middlesex Hospital, where he completed his doctorate thesis. He continued there and at the Institute of Urology in London for his sub-specialist training. He was Secretary General of the European Association of Urology 2015-2023, having previously been Chairman of the International Relations Committee, Adjunct Secretary General Responsible for Education, and Director of the European School of Urology. He was the Network Coordinator for the European Reference Network (ERN) for rare urogenital diseases and complex conditions (eUROGEN) from 2016-2019. He was the editor-in-chief of the journal Neurourology & Urodynamics from 2006-2016 and is on the editorial board of several international journals. He is an active member of many urological associations and societies and has been awarded honorary membership of 25 national urological associations. He has honorary fellowships from the Royal College of Surgeons Hong Kong, the Sri Lankan College of Surgeons, and the American College of Surgeons. He has chaired several guidelines initiatives, including the NICE GDG on Male LUTS and the ICUD Consultation on Male LUTS. BAUS awarded him the St Peter's medal in 2011, SUFU awarded him the Lifetime Achievement Award in 2015, the International Continence Society made him the inaugural member of their Hall of Fame in 2020, CAU awarded him the Shlomo Raz medal in 2022, and the SIU gave him a Distinguished Career Award in 2023.  Prof. Chapple has co-authored 850+ articles, comments, and letters in peer-reviewed journals and has written several chapters and books.

Alan J. Wein is Founders Professor and Chief of Urology and Director of the Urology Residency Program at the University of Pennsylvania. He obtained his MD training in surgery, basic urologic research and clinical urology at Penn. He holds an honorary PhD from the University of Patras, Greece and was conferred an Honorary Professorship by the Institute of Urology, Russian Ministry of Health. His clinical and research interests include, physiology/pharmacology of the lower urinary tract, evaluation and management of urinary incontinence and all types of lower urinary tract dysfunction, problems with prostate enlargement and the evaluation and management of prostate, bladder and kidney cancer.  He has received numerous awards and honors for excellence in the field of urology and has been recognized nationally and internationally through his many affiliations and professional memberships, which include the American Association of Genitourinary Surgeons (AAGUS), Clinical Society of Genitourinary Surgeons, American Surgical Association, Society of Surgical Oncology, Society of Urologic Oncology (founding member), Society of Pelvic Surgeons, Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, Société Internationale d'Urologie, American Urological Association (AUA), and the Royal Society of Medicine.   He is the recipient of numerous awards including, the Urodynamics Society Lifetime Achievement Award, the F. Brantley Scott Award of the American Foundation for Urologic Diseases, the Hugh Hampton Young Award of the AUA, the Ferdinand C. Valentine Award of the New York Academy of Medicine and the Keyes Medal by the AAGUS, which is recognized as the greatest individual citation in the specialty for outstanding contributions in the advancement of urology.  He has authored or co-authored hundreds of papers and book chapters, holds multiple editorial positions on scientific

Part 1: Non muscle invasive bladder cancer.- Ch 1. Diagnosis and management of patients.- Ch 2. Adjuvant therapy.- Ch 3. TA, T1 and carcinoma in situ.- Part 2: Prostate cancer.- Ch 4. Screening and early detection.- Ch 5. Management of metastatic disease.- Ch 6. Epidemiology.- Ch 7. Local staging of prostate cancer.- Ch 8. Management of localized disease.- Ch 9. Management of high-risk and locally advanced disease.- Ch 10. Experimental therapies.- Part 3: Muscle invasive bladder cancer.- Ch 11. Diagnosis and management.- Ch 12. Evidence relating to surgical management.- Ch 13. Role of lymph node dissection.- Ch 14. Systemic chemotherapy and immunotherapy.- Part 4: Renal cell carcinoma.- Ch 15. Diagnosis and initial management.- Ch 16. Management of Locally Advanced RCC with IVC Tumor Thrombosis.- Ch 17. Metastatic.- Ch 18. Localised Renal Cell Carcinoma.- Part 5: Testicular cancer.- Ch 19. Testicular cancer: Diagnosis and Initial Management.- Ch 20. Extended surgery.- Ch 21. Chemotherapy.- Part 6: Penile cancer.- Ch 22. Penile Cancer: Epidemiology, Pathology and Carcinogenesis.- Ch 23. Conservative management and laser ablation of superficial disease.- Ch 24. Surgical management.- Ch 25. Imaging and management of lymph node involvement in penile squamous cell carcinoma.- Ch 26. Systemic treatment: Neoadjuvant, adjuvant adn palliative.- Part 7: Treatment of non-neurogenic male urinary tract symptoms.- Ch 27. Diagnosis.- Ch 28. Pharmacotherapy.- Ch 29. Established surgical interventions.- Ch 30. Emerging treatments for non-neurogenic male LUTS.- Part 8: Treatment of Non-Neurogenic Female Urinary Tract symptoms.- Ch 31. Treatment of Non - Neurogenic Female Urinary Tract Symptoms Diagnosis.- Ch 32. Conservative and Pharmacological Treatment.- Ch 33. Surgical Treatment.- Ch 34. New Surgical Treatments and Experimental Treatments.- Part 9: Treatment of Neurogenic Urinary Tract Symptoms In Both Sexes.- Ch 35. Treatment of Neurogenic Urinary Tract Symptoms In Both Sexes:Diagnosis.- Ch 36. Pharmacotherapy and other conservative treatments.- Ch 37. Conventional minimally invasive and surgical treatments.- Ch 38. New surgical treatments.- Ch 39. New experimental treatments.- Part 10: Chronic pelvic pain.- Ch 40. Chronic Pelvic Pain.- Part 11: Priapism.- Ch 41. Priapism: Diagnosis and management.- Part 12: Penile curvature.- Ch 42. Penile Curvature: Diagnosis and Management.- Part 13: Male infertility.- Ch 43. Male infertility: Diagnosis and management.- Ch 44. Testosterone Physiology and the Diagnosis of Male Hypogonadism.- Ch 45. Testosterone and sexual function.- Ch 46. Practical perspectives in testosterone treatment.- Ch 47. Testosterone and the prostate.- Ch 48. Testosterone, metabolism, and the cardiovascular system.- Part 14: Male sexual dysfunction.- Ch 49. Erectile dysfunction.- Ch 50. Premature Ejaculation.- Ch 51. Acquired Penile Curvature.- Ch 52. Hypogonadism.- Part 15: Urological infections.- Ch 53. Asymptomatic bacteriuria.- Ch 54. Uncomplicated cystitis.- Ch 55. Recurrent cystitis.- Ch 56. Catheter-associated UTIs.- Ch 57. Pyelonephritis.- Ch 58. Prostatitis.- Ch 59. Epididymitis.- Ch 60. Urethritis.- Ch 61. Fournier's Gangrene Or Necrotizing Fasciitis Of The Perineum And External Genitalia.- Ch 62. Urosepsis.- Ch 63. Antimicrobial Prophylaxis.- Part 16: Urolithiasis.- Ch 64. Urinary Stones- Risk of Formation, Diagnosis and Initial Management.- Ch 65. Surgical interventions for urinary stone disease including SWL and indications for active stone removal.- Ch 66. The Role of Medical Treatment to Urinary Stone Clearance and Recurrence.- Part 17: Urological trauma.- Ch 67. General principles and management.- Ch 68. Renal and Ureteric Trauma.- Ch 69. Bladder Trauma.- Ch 70. Current Management Of Urinary Tract Injuries.- Ch 71. Genital Trauma.- Part 18: Urethral stricture disease.- Ch 72. Urethral Stricture Disease.- Part 19: Urotechnology.- Ch 73. Update on new technology for management of BPH.- Ch 74. Update on new technology for laparoscopy.- Ch 75. Update on new robotic devices for endourology.- Ch 76. Update on new devices for fusion biopsy of the prostate.- Ch 77. Update on New Robotic Devices for Urologic Surgery.- Ch 78. Update on new devices for navigation in endourology.- Part 20: Diseases of the Adrenal Gland.- Ch 79. Embryology of the adrenal glands.- Ch 80. Anatomy Of The Adrenal Glands.- Ch 81. Physiology of the Adrenal Gland.- Ch 82. Pathophysiology.- Ch 83. Imaging in Adrenal Tumours.- Ch 84. Surgery of the Adrenal Gland.- Part 21: Pediatric Urology.- Ch 85. Posterior Urethral Valves.- Ch 86. Vesicoureteric Reflux.- Ch 87. Megaureter.- Ch 88. UPJ obstruction.- Ch 89. Bladder exstrohy.- Ch 90. Epispadias.- Ch 91. Hypospadias.- Ch 92. Cryptorchidism.- Ch 93. Nocturnal Enuresis.- Ch 94. Daytime Lower Urinary Tract Conditions in Children.- Ch 95. Neuropathic bladder: Diagnostic procedures.- Ch 96. Neuropathic bladder, therapeutic approaches: medical and surgical management.- Ch 97. Ureterocele and Ectopic Ureter.- Ch 98. Urinary Tract Infectuons in Children.- Ch 99. Varicocele.- Part 22: The Importance of Guidelines.- Ch 100. The Importance of Clinical Practice Guidelines.- Part 23: Male hypogonadism.- Ch 101. Male Hypogonadism.- Part 24: Renal transplantation.- Ch 102. Medical aspects of renal transplantation.- Ch 103. Renal Transplantation Surgical Aspects.- Part 25: Upper tract urothelial disease.- Ch 104. Diagnosis of urothelial carcinoma of the upper urinary tract.- Ch 105. Biomarkers in Upper Tract Urothelial Cancer.- Ch 106. Non-muscle invasive disease and kidney sparing management.- Ch 107. Advanced upper tract tumors including surgery and systemic treatment.- Part 26: Primary urethral cancer.- Ch 108. Primary Urethral Carcinoma.